Cytotoxic T cell repertoire selection: A single amino acid determines alternative class I restriction

Journal of Immunology

Volumn 152, Issue 12, 1994, Pages 5603-5612

  Bergmann, Cornelia C ^a   Tong, Lili ^a   Cua, Racquel V ^a   Sensintaffar, John L ^a   Stohlman, Stephen A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RECOMBINANT VACCINE; VACCINIA VACCINE; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS ENVELOPE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; BASE SEQUENCE; BINDING, COMPETITIVE; CYTOTOXICITY, IMMUNOLOGIC; DNA, RECOMBINANT; EPITOPES; GENE PRODUCTS, ENV; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV ENVELOPE PROTEIN GP160; HIV-1; IMMUNIZATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PROTEIN PRECURSORS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0028233918     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Lanzavecchia, A. 1993. Identifying strategies for immune intervention. Science 260:937.
2. Takahashi, H., J. Cohen, A. Hosmalin, K. B. Cease, R. Houghten, J. L. Cornette, C. Delisi, B. Moss, R. N. Germain, and J. A. Berzofsky. 1988. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 85:3105.
3. Reddehase, M. J., J. B. Rothbard, and U. H. Koszinowski. 1989. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 337:651.
4. Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403.
5. Rammensee, H.-G., K. Falk, and O. Rötzschke. 1993. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol 11:213.
6. + T cells. Nature 364:158.
7. Henderson, R. A., H. Michel, K. Sakaguchi, J. Shabanowitz, E. Appella, D. F. Hunt, and V. H. Englehard. 1992. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255:1264.
8. Matsumura, M., D. H. Fremont, P. A. Petersen, and I. A. Wilson. 1992. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257:927.
9. Pamer, E. G., J. T. Harty, and M. J. Bevan. 1991. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 353:852.
10. b binding motif. J. Immunol. 150:1212.
11. Calin-Laurens, V., M.-C. Trescol-Biemont, D. Gerlier, and C. Rabourdin-Combe. 1993. Can one predict antigenic peptides for MHC class I-restricted cytotoxic T lymphocytes useful for vaccination? Vaccine 11:974.
12. d-restricted CTL epitope in the mouse hepatitis virus nucleocapsid protein. J. Virol. 67:7041.
13. Feltkamp, M. C. W., H. L. Smits, M. P. M. Vierboom, R. P Minnaar, B. M. de Jongh, J. W. Drijfhout, J. ter Schegget, C. J. M. Melief, and W. M. Kast. 1993. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol. 23: 2242.
14. d class I molecule. Eur. J. Immunol. 23:2005.
15. Missale, G., A. Redeker, J. Person, P. Fowler, S. Guilhot, H. J. Schlicht, C. Ferrari, and F. V. Chisari. 1993. HLA-A31- and HLA-w68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med. 177: 751.
16. Shirai, M., D. Pendleton, and J. A. Berzofsky. 1992. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules. J. Immunol. 148: 1657.
17. Bergmann, C., S. Stohlman, and M. McMillan. 1993. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein. Eur. J. Immunol. 23:2777.
18. Corr, M., L. F. Boyd, S. R. Frankel, S. Kozlowski, E. A. Padlan, and D. H. H. Margulies. 1992. Endogenous peptides of a soluble major histocompatibility complex class I molecule H-2 Lds: sequence motif, quantitative binding, and molecular modeling of the complex. J. Exp. Med. 176:1681.
19. d gene by DNA-mediated gene transfer. Science 215:677.
20. Goodenow, R. S., M. McMillan, M. Nicholson, B. T. Sher, K. Eakle, N. Davidson, and L. Hood. 1982. Identification of the class I genes of the mouse major histocompatibility complex by DNA-mediated gene transfer. Nature 300:231.
21. Crumpacker, D. B., J. Alexander, P. Cresswell, and V. H. Engelhard. 1992. Role of endogenous peptides in murine allogeneic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM T2. J. Immunol. 148:3004.
22. d-restricted and specific for the carboxyl terminus. Virology 189:217.
23. Stohlman, S., S. Kyuwa, J. Polo, D. Brady, W. Spaan, M. Lai, and C. Bergmann. 1993. Characterization of mouse hepatitis virus specific T cells derived from the central nervous system of JHM virus-infected mice. J. Virol. 67:7050.
24. d-restricted T cells. J. Immunol. 141: 2289.
25. d exploits a four-residue peptide-binding motif. J. Exp. Med. 178:1877.
26. Del Val, M., H.-J. Schlicht, H. Volkmer, M. Messerle, M. J. Reddehase, and U. H. Koszinowski. 1991. Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope. J. Virol. 65:3641.
27. Stauss, H. J., H. Davies, E. Sadovnikova, B. Chain, N. Horowitz, and C. Sinclair. 1992. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in human papilloma virus. Proc. Natl. Acad. Sci. USA 89:7871.
28. Kozlowski, S., M. Corr, M. Shirai, L. F. Boyd, D. Pendleton, J. A. Berzofsky, and D. H. Margulies. 1993. Multiple pathways are involved in the extracellular processing of MHC class I-restricted peptides. J. Immunol. 151:4033.
29. Moerschell, R. P., Y. Hosokawa, S. Tsunasawa, and F. Sherman. 1990. The specificities of yeast methionine aminopeptidase and acetylation of amino terminal methionine in vivo: processing of altered iso1-cytochromes c created by oligonucleotide transformation. J. Biol. Chem. 265:19638.
30. Kendall, R. L., and R. A. Bradshaw. 1992. Isolation and characterization of the methionine aminopeptidase from porcine liver responsible for the co-translational processing of proteins. J. Biol. Chem. 267:20667.
31. Sinigalia, F., M. Guttinger, J. Kilgus, D. M. Doran, H. Matile, H. Etlinger, A. Trzeciak, D. Dillessen, and J. R. L. Pink. 1988. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature 336:778.
32. Panina-Bordignon, P., A. Tan, A. Termijtelen, S. Demotz, G. Corradin, and A. Lanzavecchia. 1989. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 19:2237.
33. Johnson, R. P., A. Trocha, T. M. Buchanan, and B. D. Walker. 1992. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med. 175:961.
34. + T cells in the central region of the HIV-1 NEF protein. J. Immunol. 146:1560.
35. gag protein. J. Virol. 67:694.
36. Oldstone, M. B. A., A. Tishon, R. Geckeler, H. Lewicki, and J. L. Whitton. 1992. A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: implications for vaccination. Proc. Natl. Acad. Sci USA 89:2752.
37. Sercarz, E. E., P. V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729.
38. Carbone, F., M. Moore, J. Sheil, and M. Bevan. 1988. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides. J. Exp. Med. 167:1767.
39. Schild, H., O. Rötzschke, H. Kalbacher, and H.-G. Rammensee. 1990. Limit of T cell tolerance to self protein by peptide presentation. Science 247:1587.
40. Wauben, M. H. M., R. van der Zee, I. Joosten, C. J. P. Boog, A. M. C. van Dijk, M. C. Holewign, R. H. Meloen, and W. van Eden. 1993. A peptide variant of an arthritis-related T cell epitope induces T cells that recognize this epitope as a synthetic peptide but not in its naturally processed form. J. Immunol. 150:5722.
41. Bodmer, H. C., F. M. Gotch, and A. J. McMichael. 1989. Class I cross-restricted T cells reveal low responder allele due to processing of viral antigen. Nature 337:653.
42. Eisenlohr, L. C., J. W. Yewdell, and J. R. Bennink. 1992. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:481.
43. Parker, K. C., M. A. Bednarek, and J. E. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:163.
44. H epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes. J. Exp. Med. 179:196.
45. d class I MHC molecule. Nature 344:439.
46. Lamont, A. G., M. F. Powell, S. M. Colon, C. Miles, H. M. Grey, and A. Sette. 1990. The use of peptide analogues with improved stability and MHC binding capacity to inhibit antigen presentation in vitro and in vivo. J. Immunol. 144:2493.
47. Adorini, L., E. Appella, G. Doria, and Z. A. Nagy. 1988. Mechanisms influencing the immunodominance of T cell determinants. J. Exp. Med. 168:2091.
48. Whitton, J. L., N. Sheng, M. B. A. Oldstone, and T. A. McKee. 1993. A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J. Virol. 67:348.